Analysis of anti-tumour necrosis factor-induced skin lesions reveals strong T helper 1 activation with some distinct immunological characteristics

The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies

(2017) Patrick M. Brunner et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Distinct expression of interleukin (IL)-36α, βandγ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease

(2016) M.-A. Boutet et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

A novel molecular disease classifier for psoriasis and eczema

(2016) Natalie Garzorz-Stark et al.   EXPERIMENTAL DERMATOLOGY

Cellular and molecular immunologic mechanisms in patients with atopic dermatitis

(2016) Thomas Werfel et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Eczema as an adverse effect of anti-TNFα therapy in psoriasis and other Th1-mediated diseases: a review

(2016) Mio Nakamura et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

In Situ Mapping of Innate Lymphoid Cells in Human Skin: Evidence for Remarkable Differences between Normal and Inflamed Skin

(2016) Marie-Charlotte Brüggen et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Targeting the IFN-γ/CXCL10 pathway in lichen planus

(2016) Vito Di Lernia   MEDICAL HYPOTHESES

Cumulative Incidence of, Risk Factors for and Outcome of Dermatological Complications of Anti-TNF Therapy in Inflammatory Bowel Disease: A 14-Year Experience

(2015) Estelle Fréling et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

The Immunopathogenesis of Psoriasis

(2015) Jaehwan Kim et al.   DERMATOLOGIC CLINICS

CCL7 contributes to the TNF-alpha-dependent inflammation of lesional psoriatic skin

(2015) Patrick M. Brunner et al.   EXPERIMENTAL DERMATOLOGY

Bioinformatics approach for choosing the correct reference genes when studying gene expression in human keratinocytes

(2015) Lucian Beer et al.   EXPERIMENTAL DERMATOLOGY

Clinical improvement in psoriasis with specific targeting of interleukin-23

(2015) Tamara Kopp et al.   NATURE

NOS2 and CCL27: clinical implications for psoriasis and eczema diagnosis and management

(2014) Natalie Garzorz et al.   Expert Review of Clinical Immunology

IL-36γ Sustains a Proinflammatory Self-amplifying Loop with IL-17C in Anti-TNF–induced Psoriasiform Skin Lesions of Patients with Crohnʼs Disease

(2014) Matthias Friedrich et al.   INFLAMMATORY BOWEL DISEASES

Dendritic Cell-Secreted Lipocalin2 Induces CD8+ T-Cell Apoptosis, Contributes to T-Cell Priming and Leads to a TH1 Phenotype

(2014) Melanie Floderer et al.   PLoS One

Intraindividual genome expression analysis reveals a specific molecular signature of psoriasis and eczema

(2014) M. Quaranta et al.   Science Translational Medicine

Tissue-resident natural killer cells and their potential diversity

(2014) Dorothy K. Sojka et al.   SEMINARS IN IMMUNOLOGY

Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment

(2013) Cornelia Tillack et al.   GUT

Psoriasiform Reactions to Anti–Tumor Necrosis Factor α Therapy

(2013) Khang Nguyen et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Infliximab induces downregulation of the IL-12/IL-23 axis in 6-sulfo-LacNac (slan)+ dendritic cells and macrophages

(2013) Patrick M. Brunner et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

The multifunctional role of filaggrin in allergic skin disease

(2013) Maeve A. McAleer et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

The role of IL-22 and Th22 cells in human skin diseases

(2013) Hideki Fujita   JOURNAL OF DERMATOLOGICAL SCIENCE

Eosinophilia during Psoriasis Treatment with TNF Antagonists

(2012) Bartosz Malisiewicz et al.   DERMATOLOGY

Anti-TNF-Alpha Induced Psoriasiform Eruptions with Severe Scalp Involvement and Alopecia: Report of Five Cases and Review of the Literature

(2012) F. Osório et al.   DERMATOLOGY

The IL-36 receptor pathway regulatesAspergillus fumigatus-induced Th1 and Th17 responses

(2012) Mark S. Gresnigt et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Monocyte-derived interferon-alpha primed dendritic cells in the pathogenesis of psoriasis: New pieces in the puzzle

(2012) Árpád Farkas et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: A review and analysis of 36 cases

(2012) M. Afshar et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Psoriatic Alopecia/Alopecia Areata–Like Reactions Secondary to Anti–Tumor Necrosis Factor-α Therapy: A Novel Cause of Noncicatricial Alopecia

(2011) Leona A Doyle et al.   AMERICAN JOURNAL OF DERMATOPATHOLOGY

IL-36R ligands are potent regulators of dendritic and T cells

(2011) S. Vigne et al.   BLOOD

Interferon-α in the generation of monocyte-derived dendritic cells: recent advances and implications for dermatology

(2011) Á. Farkas et al.   BRITISH JOURNAL OF DERMATOLOGY

Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials

(2011) K. Reich et al.   BRITISH JOURNAL OF DERMATOLOGY

Mutual Antagonism of T Cells Causing Psoriasis and Atopic Eczema

(2011) Stefanie Eyerich et al.   NEW ENGLAND JOURNAL OF MEDICINE

Interleukin-36–Receptor Antagonist Deficiency and Generalized Pustular Psoriasis

(2011) Slaheddine Marrakchi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Interferon-α-Conditioned Human Monocytes Combine a Th1-Orienting Attitude with the Induction of Autologous Th17 Responses: Role of IL-23 and IL-12

(2011) Stefano M. Santini et al.   PLoS One

Severe Skin Lesions Cause Patients With Inflammatory Bowel Disease to Discontinue Anti–Tumor Necrosis Factor Therapy

(2010) Jean–François Rahier et al.   Clinical Gastroenterology and Hepatology

A Naturally Occurring, Soluble Antagonist of Human IL-23 Inhibits the Development and In Vitro Function of Human Th17 Cells

(2010) R. Y. Yu et al.   JOURNAL OF IMMUNOLOGY

A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti–interferon-alfa monoclonal antibody, in subjects with chronic psoriasis

(2010) Robert Bissonnette et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Psoriatic Skin Lesions Induced by Tumor Necrosis Factor Antagonist Therapy: Clinical Features and Possible Immunopathogenesis

(2010) Angelique N. Collamer et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Cytokine imbalance with increased production of interferon-α in psoriasiform eruptions associated with antitumour necrosis factor-α treatments

(2009) J. Seneschal et al.   BRITISH JOURNAL OF DERMATOLOGY

Predictive Factors of Eczema-Like Eruptions among Patients without Cutaneous Psoriasis Receiving Infliximab: A Cohort Study of 92 Patients

(2009) Abdolrasool Esmailzadeh et al.   DERMATOLOGY

Cutaneous side effects of anti–tumor necrosis factor biologic therapy: A clinical review

(2009) Aikaterini-Evaggelia Moustou et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: A literature review and potential mechanisms of action

(2008) Angelique N. Collamer et al.   ARTHRITIS AND RHEUMATISM

IL-4-mediated fine tuning of IL-12p70 production by human DC

(2008) Emmanuella Guenova et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Tumor necrosis factor antagonist mechanisms of action: A comprehensive review

(2007) Daniel Tracey et al.   PHARMACOLOGY & THERAPEUTICS